BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,556,000 | -33.1% | 824,400 | -22.1% | 0.01% | -40.0% |
| Q3 2021 | $3,821,000 | +29.5% | 1,058,400 | +28.4% | 0.01% | +25.0% |
| Q2 2021 | $2,950,000 | -9.7% | 824,100 | -1.4% | 0.01% | -11.1% |
| Q1 2021 | $3,268,000 | +21.7% | 835,900 | +30.7% | 0.01% | +28.6% |
| Q4 2020 | $2,686,000 | -34.2% | 639,600 | -41.5% | 0.01% | -41.7% |
| Q3 2020 | $4,080,000 | -19.5% | 1,093,900 | -5.9% | 0.01% | -20.0% |
| Q2 2020 | $5,066,000 | +21.2% | 1,161,900 | +5.4% | 0.02% | -6.2% |
| Q1 2020 | $4,179,000 | -38.3% | 1,102,600 | +2.9% | 0.02% | 0.0% |
| Q4 2019 | $6,770,000 | +222.8% | 1,071,200 | +115.0% | 0.02% | +220.0% |
| Q3 2019 | $2,097,000 | -31.4% | 498,200 | -24.2% | 0.01% | -37.5% |
| Q2 2019 | $3,055,000 | +180.0% | 656,900 | +219.2% | 0.01% | +166.7% |
| Q1 2019 | $1,091,000 | +541.8% | 205,800 | +1359.6% | 0.00% | +200.0% |
| Q2 2014 | $170,000 | +153.7% | 14,100 | +24.8% | 0.00% | 0.0% |
| Q4 2013 | $67,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |